Company & Sponsor Intelligence
University of Toronto
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials9
Recruiting2
Completed3
Countries1
Therapeutic footprint
adhddepressionout_of_scopeparkinsons
Indexed studies
NCT06127771Effects of Unblocking the Full Potential of Percept PC IPG
parkinsons · CanadaNA
parkinsons · CanadaNA
NCT01657721Working Memory Training in ADHD (The Engage Study)
adhd · CanadaPHASE1
adhd · CanadaPHASE1
NCT06436313DBS Virtual Learning Experience
parkinsons · CanadaNA
parkinsons · CanadaNA
NCT02347059L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
parkinsons · CanadaPHASE2
parkinsons · CanadaPHASE2
NCT05454943Remote Time-restricted EAting DeliverY
out_of_scope · CanadaNA
out_of_scope · CanadaNA
NCT04953637Physiotherapy and Deep Brain Stimulation in Parkinson's Disease
parkinsons · CanadaNA
parkinsons · CanadaNA
NCT05521360Autonomic Modulation Training for Police Exposed to Post-Traumatic Stress Injuries
depression · CanadaNA
depression · CanadaNA
NCT06638411Nocebo Education to Reduce the Potential Unintended Harms of Mental Health Awareness
adhd · CanadaNA
adhd · CanadaNA
NCT05402163CANadian Adaptive DBS TriAl
parkinsons · CanadaNA
parkinsons · CanadaNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →